GoHealth Inc

What they do

GoHealth operates a technology-driven health insurance marketplace, primarily selling Medicare Advantage, Medicare Supplement, and prescription drug plans. It uses a proprietary platform (Encompass) with AI and machine learning to match consumers with plans via licensed agents. The company also offers GoHealth Protect, a suite of products including guaranteed acceptance life insurance. It partners with health plans across all 50 states and the District of Columbia.

Revenue drivers

• Medicare Advantage enrollments — Primary revenue source; commissions from health plans for enrollments. Activity was deliberately reduced starting Q3 2025, contributing to lower revenue.
• Medicare Supplement and prescription drug plans — Additional Medicare product lines offered through the marketplace, though not separately quantified in provided data.
• GoHealth Protect — Enrollment-related services including guaranteed acceptance life insurance; a strategic focus area as Medicare Advantage volumes decline.

Recent performance

For fiscal 2025, revenue was $361.8M, down from $798.9M in 2024, and net loss widened to $257.1M from $2.9M. Quarterly revenue fell from $94.0M in Q2 2025 to $12.6M in Q4 2025. As of March 31, 2026, cash was $39.9M, total assets $917.9M, long-term debt $650.8M, and shareholder equity only $2.1M.

Strategy

Management has deliberately pulled back Medicare Advantage activity where first-renewal economics are unattractive, focusing instead on retention and plan fit. It is investing in proprietary agentic AI and automation to lower acquisition costs and improve efficiency. The company prioritizes cash preservation and protecting the commissions receivable, while positioning for consolidation in the fragmented broker landscape.

Risks

• Health plan partner dependency — Contracts are typically non-exclusive and terminable on short notice; health plans may reduce commissions or restrict marketing, directly impacting revenue.
• Market retrenchment — Carriers have reduced prefunded marketing spend, adjusted broker compensation, and designated some plans non-commissionable, which management expects to persist into 2026.
• Liquidity and debt burden — With only $39.9M cash and $650.8M long-term debt as of March 31, 2026, and negative operating cash flow of $121.9M in 2025, the company faces solvency pressure; bankruptcy-related 8-K filings in June 2026 signal distress.
• Delisting risk — The company received delisting notices in March and June 2026, indicating potential failure to meet NASDAQ listing rules, which could affect investor access and trading.

Outlook

Management expects the Medicare Advantage market to remain in a structural reset through 2026, with carriers prioritizing profitability over growth. The company will continue its disciplined approach to cash preservation, retention, and selective technology investment. It also anticipates consolidation in the broker landscape and positions itself to lead integration opportunities when conditions improve.